242 related articles for article (PubMed ID: 35039987)
21. Pregnancy in myasthenia gravis: a retrospective analysis of maternal and neonatal outcome from a large tertiary care centre in Germany.
Draxler J; Meisel A; Stascheit F; Stein M; Gerischer L; Mergenthaler P; Herdick M; Doksani P; Lehnerer S; Verlohren S; Hoffmann S
Arch Gynecol Obstet; 2024 Jul; 310(1):277-284. PubMed ID: 38492082
[TBL] [Abstract][Full Text] [Related]
22. TREATMENT OF MYASTHENIA GRAVIS PATIENTS WITH COVID-19: REVIEW OF THE LITERATURE.
Županić S; Lazibat I; Rubinić Majdak M; Jeličić M
Acta Clin Croat; 2022 Feb; 60(3):496-509. PubMed ID: 35282492
[TBL] [Abstract][Full Text] [Related]
23. COVID-19 in Patients with Myasthenia Gravis: Mechanisms of Respiratory Failure.
Murthy JMK; Gutta AK; Yerasu MR; Boorgu SK; Osman S; Jaiswal SK; Pidaparthi L; Gudavalli BP
Neurol India; 2021; 69(6):1772-1776. PubMed ID: 34979686
[TBL] [Abstract][Full Text] [Related]
24. An Interesting Case of Fatal Myasthenic Crisis Probably Induced by the COVID-19 Vaccine.
Sonigra KJ; Sarna K; Vaghela VP; Guthua S
Cureus; 2022 Mar; 14(3):e23251. PubMed ID: 35449619
[TBL] [Abstract][Full Text] [Related]
25. Burden of illness and costs in patients with myasthenia gravis currently receiving treatment in the United States.
Parthan A; Royston M; Thanataveerat A; East EL; Parzynski CS; Habib AA
Muscle Nerve; 2024 Feb; 69(2):157-165. PubMed ID: 38018505
[TBL] [Abstract][Full Text] [Related]
26. The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis.
Galassi G
Neurol Sci; 2022 Oct; 43(10):5803-5804. PubMed ID: 35759066
[No Abstract] [Full Text] [Related]
27. COVID-19 pandemic year in a sample of Polish myasthenia gravis patients: an observational study.
Rzepiński Ł; Zawadka-Kunikowska M
Neurol Neurochir Pol; 2022; 56(1):61-67. PubMed ID: 34346049
[TBL] [Abstract][Full Text] [Related]
28. COVID-19 and myasthenia gravis: A review of neurological implications of the SARS-COV-2.
Shah SMI; Yasmin F; Memon RS; Jatoi NN; Savul IS; Kazmi S; Monawwer SA; Zafar MDB; Asghar MS; Tahir MJ; Lee KY
Brain Behav; 2022 Dec; 12(12):e2789. PubMed ID: 36306401
[TBL] [Abstract][Full Text] [Related]
29. Letter response to "The Janus faces of SARS-COV-2 infection in myasthenia gravis and myasthenic crisis".
Nóbrega PR; Junior PHO; de Freitas HC; D'almeida JAC; Rodrigues CL
Neurol Sci; 2022 Oct; 43(10):5805-5806. PubMed ID: 35941335
[No Abstract] [Full Text] [Related]
30. Myasthenia gravis: management of myasthenic crisis and perioperative care.
Juel VC
Semin Neurol; 2004 Mar; 24(1):75-81. PubMed ID: 15229794
[TBL] [Abstract][Full Text] [Related]
31. Vaccines and myasthenia gravis: a comprehensive review and retrospective study of SARS-CoV-2 vaccination in a large cohort of myasthenic patients.
Sansone G; Bonifati DM
J Neurol; 2022 Aug; 269(8):3965-3981. PubMed ID: 35503373
[TBL] [Abstract][Full Text] [Related]
32. Lady With the Blue Hair: An Atypical Cause of Myasthenic Crisis.
Gomez Rosado JO; Perez T; Fusco KN; Ahmed F; Nelson TL; Smith TA; Ma H; Barber T
Cureus; 2024 May; 16(5):e60186. PubMed ID: 38868287
[TBL] [Abstract][Full Text] [Related]
33. Predictable recovery from myasthenia gravis crisis with plasma exchange: thirty-six cases and review of current management.
Mahalati K; Dawson RB; Collins JO; Mayer RF
J Clin Apher; 1999; 14(1):1-8. PubMed ID: 10355656
[TBL] [Abstract][Full Text] [Related]
34. Comment on "Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic status and survival" by Jakubíková et al.
Galassi G; Marchioni A
Eur J Neurol; 2022 Jan; 29(1):e5-e6. PubMed ID: 34586695
[No Abstract] [Full Text] [Related]
35. Temporal association between SARS-CoV-2 and new-onset myasthenia gravis: is it causal or coincidental?
Muralidhar Reddy Y; B SK; Osman S; Murthy JMK
BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34290032
[TBL] [Abstract][Full Text] [Related]
36. Myasthenia Gravis and Crisis: Evaluation and Management in the Emergency Department.
Roper J; Fleming ME; Long B; Koyfman A
J Emerg Med; 2017 Dec; 53(6):843-853. PubMed ID: 28916122
[TBL] [Abstract][Full Text] [Related]
37. Analysis of length of stay and treatment emergent complications in hospitalized myasthenia gravis patients with exacerbation.
Ramsaroop T; Gelinas D; Kang SA; Govindarajan R
BMC Neurol; 2023 Jan; 23(1):12. PubMed ID: 36631752
[TBL] [Abstract][Full Text] [Related]
38. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
Illa I
J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 vaccination and new-onset myasthenia gravis: A report of 7 cases and review of the literature.
Ramdas S; Hum RM; Price A; Paul A; Bland J; Burke G; Farrugia M; Palace J; Storrie A; Ho P; Standing E; Lilleker JB; Jungbluth H
Neuromuscul Disord; 2022 Oct; 32(10):785-789. PubMed ID: 36130855
[TBL] [Abstract][Full Text] [Related]
40. A diagnostic and management dilemma: combined paraneoplastic myasthenia gravis and Lambert-Eaton myasthenic syndrome presenting as acute respiratory failure.
Roohi F; Smith PR; Bergman M; Baig MA; Sclar G
Neurologist; 2006 Nov; 12(6):322-6. PubMed ID: 17122730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
